Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc KHTRF


Primary Symbol: T.GUD

Healthcare
Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Bullboard (TSX:GUD)

View:
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
Post by GoldenInvestoron Feb 26, 2024 11:37am

Ardelyx reported on thursday

Doing well today.  GUD for us.
91
Discussion
Post by wofatson Feb 23, 2024 3:54pm

AGM

We advise of the following with respect to the upcoming Meeting of Security Holders for the subject Issuer: Meeting Type : Annual General Meeting Record Date for Notice of Meeting : March 20, 2024 ...more  
119
Post by GoldenInvestoron Feb 20, 2024 9:50am

Market strategists naming healthcare

As more and more strategists speaking about broader market being played out  for now, seeing lots of opportunity in pharma space. that's a GUD thing for Knight! - seen on CNBC
98
Comment by MrMugsyon Feb 12, 2024 8:08pm

RE:RE:Sorry folks - been preoccupied elsewhere

I believe the ENDO portfolio has been stalled by government investigation.  That's taking some time to play out.  I also see ENDO trying again to move the sale forward.  As per ...more  
193
Discussion
Comment by gudisgoodon Feb 12, 2024 4:43am

RE:Sorry folks - been preoccupied elsewhere

Good to hear from you! You have a vision for something that I cannot comment on (ATE & GUD). Amal is on ATE's board, therefore safe to say GUD is quite aware of what's going on there. If ...more  
177
Discussion
Post by MrMugsyon Feb 11, 2024 11:18am

Sorry folks - been preoccupied elsewhere

As ATE heads into P2 in March and exits P2 by September ... I would expect that Knight sets up the shelf prospectus once again (previous one expired) somewhere between August - November.  I can ...more  
258
Discussion
Comment by wofatson Feb 07, 2024 12:29pm

RE:RE:RE:Armoyan

T-TSX U-NEO ATS A-Alpha O-Omega P-Pure X-Chi-X H-CX2 D-CXD       Y-Lynx   ...more  
135
Discussion
Post by GoldenInvestoron Feb 07, 2024 10:57am

Random unimportant sign via predecessor

Apologies, but who knows. dropping off a family member at airport. the security team on the drop off, is called PALADIN security!!
117
Post by gudisgoodon Feb 07, 2024 5:53am

Launches

While it's difficult to say which products are going to be launched in which countries in any given year -- and of course the impact of drug/country combinations are going to vary significantly -- ...more  
199
Comment by gudisgoodon Feb 07, 2024 5:38am

RE:Update on Portfolio's Peak Potential

Just to keep track of this... In the February 2024 presentation, the peak combined sales forecast of the pipeline is now $110M-$140M (a $40M increase on the previous figure which was at a midpoint ...more  
143
Discussion
Post by Betteryear2on Feb 06, 2024 12:57pm

Knight Therapeutics Announces Launch of Bijuva® in Canada

MONTREAL, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc., (TSX: GUD) ("Knight"), a Pan-American (ex-USA) specialty pharmaceutical company, announced today the launch of BIJUVA ...more  
127
Post by GoldenInvestoron Feb 06, 2024 10:24am

Capacity constraints in market

Manufacturing is BIGGEST HURDLE for new drugs just discussed on CNBC. capacity buildout issues for  drugs & drugs beyond weight loss drugs . Eg cancer drugs, dementia and others genius ...more  
120
Post by GoldenInvestoron Feb 06, 2024 10:21am

Demand for innovative new drugs

So much demand for innovative new drugs and  therapies being talked about in the news.   So many more new innovative new drugs and other therapies still to come, that are in ...more  
115
Prev 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 ... Next
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Dealroom for high-potential pre-IPO opportunities